Nanoparticles accumulate a layer of host factors on their surface (protein corona) in biological fluids, which influences the nanoparticle activity. We hypothesized that viruses also constitute nanoparticles in this respect and we provide evidence for the existence of a viral protein corona that has implications for viral infectivity, immune cell activation and catalysis of amyloid aggregation. We demonstrate that respiratory syncytial virus (RSV), a major cause of respiratory tract infections, accumulates a rich and distinctive protein corona in different biological fluids including human plasma, human bronchoalveolar lavage fluid, non-human primate plasma and fetal bovine serum. Additionally, corona pre-coating differentially affects viral infectivity and its ability to activate human monocyte-derived dendritic cells (moDCs) depending on the biological fluid. Furthermore, we demonstrate that RSV can bind and catalyze the amyloid aggregation of an amyloidogenic peptide derived from the islet amyloid polypeptide (IAPP) via surface-assisted nucleation. Similarly, we show that herpes simplex virus 1 (HSV-1) possesses a protein corona and catalyzes the amyloid aggregation of the amyloid-beta (Aβ 42 ) peptide which is the major constituent of amyloid plaques in Alzheimer's disease (AD). We also show that HSV-1 infection accelerates Aβ 42 aggregation in the hippocampi of a mouse model of AD. Our results provide a proof-of-concept for the presence of a viral protein corona layer that is dependent on the microenvironment and influences viral-host interactions. Additionally, the demonstration of corona-driven amyloid catalysis illustrates convergence between viral and amyloid pathologies in the extracellular environment suggesting a novel mechanistic link that warrants further investigation.
Introduction
The term "protein corona" refers to the layer of proteins that adhere to the surfaces of nanostructures when they encounter biological fluids. Nanoparticles adsorb biomolecules in complex biological fluids due to the high free energy of their surfaces 1 . The importance of the corona layer stems from the fact that it constitutes the actual surface of interaction with biological membranes or "what the cell sees" in the in-vivo context 2 . Hundreds of proteins have been identified to confer a distinct biological identity of nanoparticles in different microenvironments depending on their size, chemistry and surface modification (reviewed in [3] [4] [5] ). These factors were found to be critical determinants of the biodistribution and pharmacodynamics of nanoparticles 6 . On the other hand, the ability of the surfaces of nanoparticles to partially denature certain corona proteins exposing "cryptic epitopes" highlights the role of the protein corona in the toxicology of nanoparticles [7] [8] [9] . The formation of a protein corona is particularly important in the context of nanoparticle interaction with amyloidogenic peptides such as amyloid beta (Aβ), α-synuclein and islet amyloid poly peptide (IAPP), which are associated with human diseases such as Alzheimer's disease, Parkinson's disease and diabetes mellitus type 2 disease, respectively. Nanoparticles have been shown to catalyze amyloid formation via binding of amyloidogenic peptides in their corona, thereby increasing local peptide concentration and inducing conformational changes that facilitate β-sheet stacking and fiber formation [10] [11] [12] . This surface-assisted nucleation has been demonstrated for several nanoparticles with different amyloidogenic peptides including β2-microglobulin, IAPP, Aβ42 and α-synuclein 10, 11, 13 . Similarly, this catalytic process was shown to be dependent on particle size, curvature and surface chemistry 11, 13 .
Here, we studied viruses in terms of their biophysical equivalence to synthetic nanoparticles in extracellular environments. As nanosized obligate intracellular pathogens, viruses lack replicative capacity outside the cell, and can thus be expected to interact with host factors in the microenvironment similar to synthetic nanoparticles.
In the current work, we used well-established techniques of nanotechnology, to study the surface protein interactions of infectious viruses. We investigated the protein corona of respiratory syncytial virus (RSV) in different biological fluids and its influence on viral infectivity and immune cell activation. Additionally, we studied the interaction of both RSV and HSV-1 with amyloidogenic peptides.
RSV is an enveloped orthopneumovirus with a diameter between 100 and 300 nm and a single stranded negative-sense RNA genome with 10 genes encoding 11 proteins 14, 15 . It is a leading cause of acute lower respiratory tract infections in young children worldwide causing up to an annual estimate of 34 million cases 16 .
By the first year of life, nearly 70% of children get infected with RSV at least once; and this percentage rises up to 90% by the second year of age causing up to 196,000 yearly fatalities 17 . Reinfection with RSV occurs throughout life, usually with mild local symptoms in the upper airways 18 . However, reinfection in the elderly and immunocompromised individuals can lead to severe clinical disease in the lower airways. While natural infection leads to the production of neutralizing antibodies, the ability of these antibodies to protect from subsequent RSV infections appears to be incomplete 19, 20 . Neither a vaccine nor an antiviral therapy is yet available except for passive immunization using anti-RSV monoclonal antibodies such as palivizumab, which reduces RSV-associated hospitalization by 55% in infants at high risk 21, 22 . Early vaccine trials using formalininactivated RSV led to enhanced disease with up to 80% of vaccinees being hospitalized and two dying 18, 20 .
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This led to the hypothesis that the host immune responses play an important role in the pathophysiology of airway disease caused by RSV.
HSV-1 is an example of another virus with high prevalence, infecting nearly 70% of the human population 23 .
HSV-1 is a double-stranded DNA virus consisting of an icosahedral nucleocapsid surrounded by tegument and envelope with virion sizes ranging from 155 to 240 nm 24 . HSV-1 is a neurotropic virus that infects peripheral sensory neurons and establishes latency 25 . Latent HSV-1 is occasionally reactivated causing peripheral pathology and under certain circumstances it can migrate into the central nervous system causing herpes simplex encephalitis; the most common cause of sporadic fatal viral encephalitis 25, 26 . In the context of the current work we focused on the presumptive role of HSV-1 in the pathology of Alzheimer's disease (AD) 27 . A number of risk factors have been associated with AD, including the E4 allele of the apolipoprotein E (APOE), diabetes, vascular pathology, neuroinflammation and infections 28 . Among the infections that have been implicated in AD, several recent studies have supported the theory of a significant role of HSV-1 in AD 27 . HSV-1 DNA was found to be localized within AD amyloid plaques. In AD brains, 80% of the amyloid plaques contained HSV-1 DNA, while only 24% of the viral DNA was associated with plaques in normal aged brains 29 . In addition, the presence of anti-HSV IgM antibodies, which indicate HSV reactivation, is correlated with a high risk of AD 30 . Moreover, HSV-1 infection has been shown to promote neurotoxic Aβ accumulation in human neural cells and to the formation of Aβ deposits in the brains of infected mice 31 . Despite these correlations, to our knowledge, a direct role of HSV-1 in the process of amyloid aggregation no evidence has been found supporting.
In the present study, we demonstrated that upon encountering different biological fluids, RSV and HSV-1 accumulated extensive and distinct protein coronas that were biological fluid-dependent. The various coronas exert markedly different effects on RSV infectivity and capacity to activate moDCs. Moreover, upon interaction with an amyloidogenic peptide derived from IAPP, RSV accelerated the process of amyloid aggregation via surface-assisted nucleation. This amyloid catalysis was also demonstrated for HSV-1 and the Aβ 42 peptide. Our findings highlight the potential importance of viral protein corona interactions for viral pathogenesis and the direct mechanistic overlap between viral and amyloid pathologies.
Results

RSV accumulates distinctive protein coronas in different biological fluids
Based on the extensive literature describing the significant role of corona factors in synthetic nanoparticle functionality, we used established techniques to answer questions regarding RSV pathogenicity Assessment of the proteomics data by principle component analysis (PCA) showed that RSV and HSV-1 samples separated from another and that viral samples were well separated from the control samples with tight replicate (triplicate) grouping ( Fig. 1 and Supp. Fig. 2 ). In order to determine if the most abundant corona factors were the most abundant proteins in the biological fluids, the crude fluids were also analyzed by mass spectrometry. The top 10 most abundant proteins identified are presented Table 1 and Supp. Table 1 for RSV and HSV-1, respectively. Similar to previous findings for nanoparticles 33 , our data showed that the most abundant proteins in the protein corona were not necessarily the most abundant in the biological fluids. This, together with the PCA analyses comparing RSV to HSV-1 to the controls, indicates enrichment of particular corona factors depending on the surface properties of the virus. Moreover, proteomic data sets were visualized by heat map and hierarchical clustering revealing an extensive protein corona signature for viral samples in each biological fluid (Fig. 1D ). While the serum-free viral particles contain some host factors that are incorporated during virus replication and budding from the cells, the virus was able to subsequently accumulate a different set of host factors which were dependent on the biological fluid. As such, a characteristic protein fingerprint was associated with each biological fluid. The viral corona factors present in each biological fluid are listed in Supp. Table 2 .
Additionally, we used transmission-electron microscopy (TEM) in order to visualize the viral corona layer. A fuzzy layer of factors was observed interacting with the viral surface during cell membrane encounter in HP and FBS conditions, which was absent in serum free conditions (Fig. 2) . We also performed cryoimmunoelectron microscopy using antibodies for certain proteins that were detected in the viral corona proteomic analysis. In serum-free conditions, we used anti-RSV F-protein antibody. For HP and BAL coronas, we used anti-human IgG and anti-surfactant protein A antibodies, respectively. The bound antibodies were detected using secondary antibodies coated with 10 nm gold nanoparticles. As shown in Supp. Fig. 3 , corona factors were bound to the surface of RSV and labelled with the respective antibodies. Taken together, the electron microscopy studies demonstrated that RSV accumulated a layer of corona factors that are involved in cellular interactions.
Protein corona influences viral infectivity and monocyte-derived dendritic cells (moDC) activation
To investigate if differential corona composition affects viral infectivity, virions produced under serum-free conditions were pre-incubated with different biological fluids before infection of HEp-2cells. The RSV virions were incubated with biological fluids at a protein concentration of 0.3 mg/ml (equivalent to 5% v/v) for 1 h at 37 ˚C then diluted 10 times in serum-free medium before adding to the cells at final MOI of 1. Corona pre-coating had a significant effect on viral infectivity as demonstrated by the differential frequency of eGFP expressing cells quantified by flow cytometry (Fig. 3A-B and Supp. Fig 4) . HP corona pre-coating significantly reduced infectivity compared to serum-free conditions, while FBS and MP led to 5-6 fold enhancement in infectivity.
BAL corona also enhanced infectivity, but to a lower extent as compared to MP and FBS. Moreover, fluorescence microscopy revealed syncytia formation of cells infected with BAL, MP and FBS coronas (Supp. enhancement increased with concentration, the MP effect decreased after a protein concentration of 0.3 mg/ml was reached. This can be due to the increase of unbound corona factors that compete with bound factors for cellular receptors. Furthermore, we investigated the effect of corona pre-coating on viral neutralization via palivizumab, which is a humanized monoclonal antibody directed against the F protein of RSV. We found that the enhancing effects of the coronas were completely lost in the presence of the antibody and that the antibody neutralization curves looked very simillar in the presence and the absence of the viral corona (Supp Fig. 6B ).
This data demostrated that high affinity antibodies are able to compete out corona factors to impart host protection. Moreover, corona pre-coating also affected viral entry kinetics as suggestedby different levels of infectivity upon utilizing the citric acid wash entry assay (Supp. Fig. 7 ) .
Furthermore, we investigated the effect of different coronas on the activation of human monocyte-derived dendritic cells (moDCs) by quantifying the expression of the maturation marker CD86. Differentiated moDCs were infected by virions produced under serum-free conditions with different corona pre-coatings for 4h in serum-free conditions. The cells were then washed and incubated in serum-containing medium for 72h prior to flow cytometry analyses. Only the BAL pre-coated virions were able to induce moDC activation and increase CD86 expression to levels similar to the TLR3 ligand polyI:C ( Fig. 3C-F) . Notably, adding BAL or RSV per se did not activate the cells, showing that it was the pre-coating with BAL and RSV, which provided the conditions enabling moDC activation. In addition, BAL pre-coating enhanced RSV infectivity in moDCs as quantified by flow cytometry of eGFP expression ( Fig. 3E-F ). Altogether, this shows that pre-incubation of virions produced under serum-free conditions in different biological fluids to allow a corona formation greatly affects infectivity and the ability to induce moDC activation.
Differential RSV corona composition
As a virus that infects nearly 100% of the human population, it is expected that anti-RSV antibodies would be present in biological fluids of human origin. Indeed, both HP and BAL contained high levels of anti-RSV IgG antibodies as demonstrated by ELISA (Supp. Fig. 8 ). The set of factors that were only present in the HP corona and not in the other conditions comprised several antibodies and complement factors (highlighted in Fig. 4A ).
Moreover, gene list enrichment analyses of HP corona revealed an enrichment of immunological gene ontology (GO) terms such as complement activation and humoral immune response (Fig. 4B) . The HP corona proteomic profile was consistent with the observed inhibition of infectivity (neutralization), indicating that the corona characterization methodology is representative of the actual layer of host factors that surrounds the viral particle.
Notably, despite having comparably high levels of virus-specific IgG antibodies, BAL imparted opposite effects on infectivity compared to HP, which we speculate is related to a different viral corona composition. At the proteomics level, GO analysis revealed that the viral BAL corona comprised a different set of factors that are less enriched in immunological components and more enriched in factors related to adhesion, anchoring, protein targeting to membrane, interspecies interaction, mutualism through parasitism, protein complex binding, and macromolecular complex binding (Fig.4) . On the other hand, both FBS and MP enhanced viral infectivity several folds over serum-free conditions in HEp-2 cells. GO analysis revealed that they are also enriched in terms such as anchoring, adhesion, receptor binding, protein complex binding, unfolded protein binding, interspecies interaction, viral process, and mutualism through parasitism (Supp. Fig. 9 ).
RSV catalyzes amyloid aggregation
Since nanoparticles are known to bind amyloidogenic peptides in their coronas leading to induction of amyloid aggregation, we next investigated whether viruses are also capable of this particular corona interaction. We thus investigated the interaction of RSV with a model amyloidogenic peptide (NNFGAIL) derived from the IAPP.
We traced the ability of RSV to accelerate amyloid kinetics using the well-established thioflavin T (ThT) based methodology. The ThT dye changes its fluorescence emission spectrum upon binding to amyloid fibrils, and plotting relative changes in the fluorescence intensity against time illustrates the kinetics of the amyloid formation process 34 . Using the ThT assay, we found that the presence of RSV particles significantly accelerated amyloid formation of NNFGAIL compared to non-infected cell supernatant demonstrating that RSV can act as a catalytic surface for amyloid aggregation (Fig. 5A ). Additionally, extensive fiber networks were observed with TEM within 100 min. of incubation with RSV ( Fig. 5B ) and some virions were located at the tip of these fibers (Fig. 5C ). Moreover, RSV catalytic activity was more efficient than lipid vesicles of similar size; however, it was dramatically reduced in the presence of 5% FBS, indicating a competition between the peptide and other corona factors for the viral surface ( Fig. 5D ). On the other hand, RSV failed to catalyze the amyloid aggregation of GNNQQNY peptide, which is derived from yeast prion protein (Fig. 5E ). This, in turn, indicates that such interactions are not universal to all amyloidogenic peptides but rather selective depending on the virus/peptide pair.
HSV-1 accelerates the kinetics of Aβ 42 amyloid formation
The finding that viral surfaces can serve as catalysts for amyloid formation warranted further investigation and confirmation using another virus-peptide system. To this end, we investigated HSV-1 and the Aβ 42 peptide, whose aggregation is a major hallmark of AD. Recently, there has been an increasing body of reports suggestive of a correlation between HSV-1 infection and AD, reviewed in 27 . However, evidence of a direct role of HSV-1 in the process of amyloid nucleation and subsequent fibril growth is currently lacking.
We found that HSV-1 significantly accelerated amyloid formation of Aβ 42 compared to non-infected cell supernatant (Fig. 6A ). The catalytic activity was reduced by the presence of FBS, also indicating a competition at the viral surface ( Fig 6B) . In addition, HSV-1 was more efficient than liposomes in accelerating the amyloid aggregation kinetics (Fig. 6C) . Furthermore, the propensity of HSV-1 mediated amyloid catalysis is higher for the more amyloidogenic Aβ 42 peptide compared to the shorter, less amyloidogenic Aβ 40 peptide (Fig. 5D) . As a control, we compared the kinetic curves of the virus-containing medium vs naked medium upon incubation with
ThT alone without a peptide. As shown in Supp. 
Discussion
Viruses rely on the host cellular machinery of the host for replication, production of viral proteins and viral assembly. However, outside cells, viruses share many biophysical properties with nanoparticles. Based on this biophysical equivalence, we hypothesized that viruses accumulate a rich and selective protein corona layer in extracellular environments similar to nanoparticles. Examples of particular host factors that bind to viral surfaces have previously been described. For example, lipoproteins such as apolipoprotein E (APO E) were shown to be essential for hepatitis C virus (HCV) infection 36 . Furthermore, coagulation factors such as factor X were shown to directly bind adenovirus leading to liver tropism 37, 38 . Other soluble components such as Gas6 were shown to contribute to the infectivity of lentiviral vectors even when pseudotyped with multiple types of envelope proteins 39 . Furthermore, soluble heparin sulfonated proteoglycans (HSPGs) were shown to enhance the infectivity of human papillomavirus (HPV) 40 . Interestingly, amyloids derived from prostatic acidic phosphatase (PAP) in semen were shown to enhance HIV-1 infectivity by several orders of magnitude 41 . These studies illustrate the significant role of host proteins that adhere to viral surfaces. However, to the best of our knowledge, there is no previous work that has comprehensively studied and characterized the entire corona of a virus in different biological fluids.
In this work, we used proteomics to study viral protein corona enrichment in different biological fluids. We investigated the RSV protein corona in biological fluids that are relevant to viral tropism, zoonosis and culturing conditions. As RSV is a virus tropic to the respiratory tract, we compared the viral corona in human BAL versus HP from young healthy volunteers. We also investigated the RSV corona in plasma from rhesus macaques which are used as a model in RSV studies and vaccine development 42 . Moreover, we studied the corona in FBS, which is the most commonly used cell growth supplement for viral production and in-vitro studies. We compared the RSV corona to HSV-1 and lipid vesicles of similar size with positively or negatively charged surfaces. PCA
showed that the RSV corona profile is separable from that HSV-1 and lipid vesicles ( Fig. 1 and Supp. Fig. 2 ).
Also, while the corona profile was dependent on the biological fluid, it was not a mere reflection of the most abundant proteins as shown in the Table 1 and Supp. Table 1 of the top 10 proteins present in the viral coronas in comparison to crude biological fluids.
The protein corona layer was visualized using TEM, which revealed a fuzzy layer surrounding the viral surface involved in cellular interactions (Fig. 2) . Additionally, using cryoimmuno electron microscopy, we could detect specific protein hits from the proteomic analysis (human IgG in HP and surfactant protein A in BAL) on the surface of RSV upon incubation with HP or BAL, respectively (Supp. Fig. 3 ). Functionally, the coronas from the different biological fluids enhanced RSV infectivity except for the HP corona. In accordance with the biological activity, proteomic analysis of the HP corona revealed that it was enriched in antibodies and complement factors ( Fig. 1D & Fig. 3 ). An added advantage of the corona fingerprinting technique is that it allows for an unbiased and comprehensive characterization of the components of the protein complex involved in RSV neutralization, which may reveal additional functionally important factors. In contrast to the HP corona, the BAL corona enhanced viral infectivity in both HEp-2 cells and moDCs despite having equally high anti-RSV IgG antibody titers as compared to HP. The BAL corona profile was different including proteins that are related to membrane localization, interspecies interaction and adhesion (Fig. 3) . It can be speculated that the differential BAL corona profile might affect the formation of a neutralization complex, explaining pulmonary RSV reinfection even in individuals with high IgG titers 19 . An alternative, not mutually exclusive explanation is the presence of differential anti-RSV specific antibodies affecting RSV neutralization in BAL as compared to HP.
Furthermore, pre-incubation of RSV with was BAL the only condition that induced moDC activation, while this was not observed for any of the controls using BAL, or other RSV conditions (Fig. 3 ). This demonstrates a role of corona factors in virus-induced immune activation that may contribute to disease pathophysiology. The list of proteins that are uniquely detected in the BAL corona included pulmonary surfactants which were shown to enhance RSV infectivity 43 , nucleolin and EGFR, which were shown to be important for RSV cell entry 44, 45 , adhesion molecules (such as tetraspanin, neuroplastin, integrin and cadherin), coxsackievirus/adenovirus receptor, poliovirus receptor and zinc finger CCCH-type antiviral protein 1. Taken together, this shows that extracellular RSV can interact with microenvironmental factors forming a "viral corona". As the corona layer is a rich and complex layer, the final biological effect is expected to be dependent on a multitude of corona factors rather than a single protein. Moreover, it is not the combination of the proteins in the biological fluids per se that affect the outcome but rather the protein layer building up around the virus, as shown by the lack of moDC activation by BAL fluid alone (Fig. 3) .
Additional biological fluids investigated in our study included FBS and MP and they both enhanced the infectivity of RSV. GO analysis suggests a role of these factors in interspecies interaction, mutualism, viral process, protein complex binding, unfolded protein binding anchoring and adhesion. Factors in FBS that may contribute to these effects include C4b-binding protein alpha-like which is a complement inhibitor, isoform 2 of fermitin family homolog 2 which binds to membranes enriched in phosphoinositides and enhances integrinmediated adhesion 46 and hepatitis A virus cellular receptor 1. In the MP corona, several adhesion proteins were found including: fibronectin isoform 4 preproprotein, endothelial cell-selective adhesion molecule, fermitin family homolog 3 short form and zyxin. The MP corona also includes receptor ligands such as: transferrin andC-X-C motif chemokine together with tetherin (isoform 2 of Bone marrow stromal antigen 2) which possesses antiviral properties based on its ability to tether viruses to the cell membrane preventing their release 47 . Taken together, this illustrates that the observed functional effects of the viral protein corona is most likely mediated by a combination of factors that are enriched on the viral surface and not by a single factor. Since many viruses bind to several receptors and co-receptors, such interactions might be taking place in a multivalent manner 48 .
Notably, our results on FBS and MP show that viral pre-coating with a protein corona via straightforward exposure to low concentrations of biological fluids from different species can have a significant impact on infectivity. It highlights that viral protein corona has to be taken into consideration in relation to zoonotic studies and development of animal models as well as pathogenicity and immune reactivity.
Moreover, to investigate whether viral corona interactions with host factors involves surface-assisted nucleation,
we incubated RSV with a model amyloidogenic peptide derived from IAPP; NNFGAIL. We found that RSV accelerated the kinetics of amyloid aggregation, demonstrating that viral particles, similar to synthetic nanoparticles, are capable of amyloid catalysis via surface-assisted nucleation (Fig. 5) . Notably, amyloidogenic peptides can also be found in the RSV corona profile in BAL (isoform 2 of major prion protein) and in MP (amyloid beta A4 protein). This suggests that viral interaction with amyloidogenic peptides is feasible in complex biological fluids. In order to investigate if this catalytic mechanism extends to other virus-amyloid pairs, we evaluated whether HSV-1 could accelerate the amyloid kinetics of Aβ 42, which is implicated in AD.
Several recent studies have suggested HSV-1 involvement in AD 27 . Herein, we found that HSV-1 accelerated the kinetics of amyloid aggregation of Aβ 42 and to a lesser extent the aggregation of Aβ 40 (Fig. 6 ). (Fig. 6F) , demonstrating that the corona-driven catalysis can take place in-vivo.
Taken together, our data on RSV and HSV-1 demonstrated that viruses can physically act as nano-surfaces capable of catalyzing amyloid nucleation and leading to accelerated fibril formation. Very recently, adding to the accumulating evidence of a role of herpes viruses in AD, a multiscale analysis study of different AD cohorts pointed to a disruption of molecular, genetic, and clinical networks by herpes viruses 49 . The authors interpret the correlation in the context of the "antimicrobial hypothesis" that suggests that Aβ is an antimicrobial peptide that is released to sequester infections 50 . This hypothesis has its roots in the biflocculant hypothesis suggested earlier, where Aβ is thought to be released to sequester neurotoxins in plaques 51 . Here, we present an alternative explanation of these correlations based on the "corona hypothesis" suggesting that the virus interacts with extracellular host factors as part of the pathogenesis, and the bound peptides do not necessarily possess an immunological and/or an antimicrobial function. This is further corroborated by studies showing that amyloids can enhance the infectivity for viruses such as HIV and HSV 41, 52 . In this case, the virus will evolve to optimize these interactions via natural selection in order to maintain a chronic state of infectivity rather than avoid them.
In addition, no studies so far have evaluated whether Aβ knock-out animals are more vulnerable to infections, as shown for animals lacking classical antimicrobial peptides such as LL37 53 . Moreover, the extra-protection demonstrated in animals overexpressing Aβ might be due to the overlap of certain structural features between amyloids and antimicrobial peptides that is magnified by overexpression; however, this does not necessarily indicate that amyloids are antimicrobial peptides in physiological conditions 54 . Furthermore, due to the documented stability of corona interactions, we speculate that viruses might be able to carry amyloidogenic nuclei (seeds) on their surfaces leading to amyloid propagation. While our results do not prove disease causality, they present an alternative mechanistic explanation of the clinical and experimental correlations drawn between HSV-1 and AD, which requires further investigation.Finally, the implication that viruses are capable of inducing conformational changes in bound host factors leading to exposure of cryptic epitopes may prove important for better understanding the correlation between viruses and autoimmune diseases.
To conclude, the current work was based on the biophysical equivalence between viruses and synthetic nanoparticles in extracellular environments. We demonstrated that nanotechnological concepts such as the protein corona and surface-assisted nucleation can be extended to infectious viruses leading to novel insights on viral-host interactions. We showed that viral protein corona accumulation and amyloid catalysis are two aspects of the same phenomenon, namely viral surface interaction with extracellular host proteins. This phenomenon leads to the modulation of how viruses interact with cells and/or the induction of conformational changes in bound proteins that leads to accelerated amyloid aggregation. These findings highlight the potentially critical role of viral extracellular interactions in viral infectivity and in relation to extracellular protein pathology.
Materials and Methods
Viral and cell culture
HEp-2 cells, a human laryngeal carcinoma cell line, were used for RSV viral culture and infectivity experiments.
Preparation of RSV A2/eGFP stocks was performed using VP-SFM serum-free, ultra-low protein medium initial viral quantification purposes, a commercially available RSV-A2 strain was purchased from (Advanced Biotechnologies Inc). The MOIs used for infectivity experiments were based on genome copies/ml measured by qPCR and the infectious viral titers were measured as TCID 50 on HEp-2 cells as described earlier 56 . Briefly, 10-fold dilutions of virus were added onto Hep2 cells for 2 h at 37°C, then inoculum was removed, and fresh maintenance medium was added. The plates were examined in the microscope on day7 and the number of wells for each dilution that was positive for GFP was noted. The titer was calculated according to the method of Karber. The viral stock of 7x10 8 genome copies/ml corresponded to log 10 6.7 TCID 50 /mL.
For HSV-1, strain F HSV-1 stocks were prepared by infecting African green monkey kidney (VERO) cells at 80-90% confluency in DMEM (Invitrogen) with 5% FBS or in serum-free DMEM. The virus was harvested 2 d after infection. Cells were subjected to two freeze-thaw cycles and spun at 20,000 g for 10 min to remove cell debris. Clarified supernatant was aliquoted and stored at -80°C until use. Non-infected cell medium was prepared with the same procedure without viral infection. Plaque assay was used to determine viral titers. 10-fold dilutions of virus were added onto VERO cells for 1 h at 37°C, then inoculum was removed, and fresh medium containing 0.5% carboxymethyl cellulose (Sigma Aldrich) was added. Cells were fixed and stained 2d later with a 0.1% crystal violet solution and the number of plaques was counted.
Human BAL samples
The use of human BAL samples for the current study was approved by the Regional Committee for Ethical
Review in Stockholm (D. No 2016/1985-32). All donors had given oral and written informed consent to participate in the bronchoscopy study, in line with the Helsinki Declaration. The clinical characteristics of the utilized cohort of healthy volunteers were described in detail elsewhere 57 . Briefly, healthy subjects of male and female gender were recruited at the Lung Allergy Clinic, Karolinska University Hospital, Solna. These subjects were examined after denying regular tobacco smoking and history of allergy or lung disease during an interview.
The final inclusion required that these subjects displayed no signs of pulmonary or disease during clinical examination, spirometry and clinical blood testing including electrolytes, white cell differential counts and Creactive protein. Bronchoscopy with BAL (5 x 50 ml of sterile and phosphate-buffered saline) was performed according to clinical routine at Karolinska University Hospital, Solna, as previously described 57 . BAL was concentrated using 5 kDa cutoff 4 ml spin concentrator (Agilent Technologies, USA) before infectivity experiments.
Lipid vesicle preparation and characterization
1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DSPG), and cholesterol were bought from Avanti Polar Proteins were digested with trypsin (MS gold, Promega) 0,1 µg/µl overnight at 37 °C (trypsin : protein ratio 1:50). For sample clean-up, the samples were applied to strong cation exchange SCX microcolumns (Strata-XC Phenomenex). The microcolumns were initially washed with 100% methanol followed by MilliQ grade water.
The samples were adjusted to >0.1% formic acid and then applied to the columns. After washing with 30% methanol and 0.1% formic acid the samples were eluted with 30% methanol and 5% ammonium hydroxide.
Samples were dried in a SpeedVac and submitted to mass spectrometry (MS). For MS analysis, samples were dissolved in 3% ACN, 0.1% formic acid to end-concentration 1µg/µL .Two microliters of sample were analyzed with a hybrid LTQ-Orbitrap Velos mass spectrometer (ThermoFisher, USA). An Agilent HPLC 1200 system Chlorocebus sabaeus version 180613 using a 1% peptide false discovery rate (FDR) cut-off limit. For samples containing proteins from multiple species, combined species databases were created by merging the corresponding protein databases. For label-free quantification, protein MS1 precursor area was calculated as the average of the top-three most intense peptides. Only proteins significantly detected (FDR 1%) in all three technical replicates in each sample were used in the downstream data analysis.
Data analysis
PCA analysis and hierarchical clustering of the filtered proteomics data (described above) was performed using ClustVis 58 . Gene ontology gene list enrichment analysis was performed using ToppFun 59 . For other 14 experiments, non-parametric Kruskal-Wallis unpaired test was used followed by Dunn's post-test or MannWhitney test was used to compare the data. Six replicates from two independent experiments. P-value: ** P ≤ 0.01. Statistics were calculated using GraphPad Prism 7 software.
ELISA
The detection of specific anti-RSV IgG antibodies in biological fluids was performed using Human AntiRespiratory syncytial virus IgG ELISA Kit (ab108765, abcam®, Sweden), according to manufacturer's protocol.
All biological fluids (FBS, HP, MP, BAL) were diluted to a protein concentration of 0.3 mg/ml before performing the assay and results were compared to the positive, cutoff, and negative controls provided by the kit manufacturer.
RSV infectivity
HEp-2 cells were seeded in maintenance medium until they reached 50-60% confluency. On the day of infection, the cells were washed twice with warm PBS and medium was changed to VP-SFM with gentamycin. Before For viral uptake experiments, citric acid wash entry assay with different protein coronas was performed according to procedure described in 60 .
MoDC differentiation
Human monocytes were negatively selected from buffy coats using the RosetteSep Monocyte Enrichment Kit (1mL/10mL buffy coat; StemCell Technologies) and differentiated into moDC, using GM-CSF (250ng/mL; PeproTech) and IL-4 (6.5ng/mL; R&D Systems) for 6 days in 37°C, 5% CO 2 at a density of 5x10 5 cells/mL in RPMI 1640 completed with 10% FCS, 1mM sodium pyruvate, 10mM HEPES, 2mM L-glutamine, and 1% and penicillin/streptomycin (ThermoFisher, USA) as previously described 61 . Immature moDC were exposed to RSV pre-incubated with different biological fluids for 4h in serum free media, washed and then incubated in serum containing medium for 72 h before analyses of CD86 and RSV-eGFP expression. Dead cells were excluded using Live/Dead fixable near-IR dead cell stain kit (ThermoFisher). Flow cytometry sample data were acquired on a Fortessa (BD Biosciences) and the analysis was performed in FlowJo software (TreeStar). 
Thioflavin-T Assay
Animal experiments
To evaluate the impact of the HSV-1 on brain β-amyloid (Aβ) levels, 3-month-old transgenic 5XFAD mice (purchased from Jackson Laboratories, Bar Harbor, Maine, US) were randomly divided into 2 groups. The animals were injected either with the HSV virus or non-infected supernatant using a micro-infusion pump (The Harvard Apparatus Pump Series, Harvard Bioscience, USA) into the right lateral ventricles as previously described 62 . Briefly, surgical anaesthesia was induced with 5% isoflurane and maintained with 1.8% isoflurane 
